Deciphera Pharmaceuticals, Inc. Human Resources Contracts & Agreements
32 Contracts & Agreements
- Bonus & Incentive Agreements (11 contracts)
- Compensation Agreements (4)
- Consulting Agreements (1)
- Employment Agreements (13)
- Non-Competition Agreements (1)
- Transition Agreements (2)
- Employment Agreement, between Deciphera Pharmaceuticals, LLC and (Filed With SEC on February 7, 2024)
- Compensation Recovery Policy (Filed With SEC on February 7, 2024)
- Consulting Agreement between Deciphera Pharmaceuticals, LLC and Daniel L. Flynn, Ph.D., dated August 1, 2023 (Filed With SEC on October 30, 2023)
- Transition Agreement b (Filed With SEC on October 30, 2023)
- Form of Performance-Based Restricted Stock United Award Agreement for Non-U.S. Grantees under 2017 Stock Option and Inventive Plan (Filed With SEC on May 3, 2023)
- Form of Performance-Based Restricted Stock United Award Agreement for Company Employees under 2017 Stock Option and Inventive Plan (Filed With SEC on May 3, 2023)
- Deciphera Pharmaceuticals, Inc. Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 7, 2023)
- Employment Agreement, between Deciphera Pharmaceuticals, LLC and Stephen Ruddy (Filed With SEC on February 9, 2021)
- Amendment No. 1 to Employment Agreement, between Deciphera Pharmaceuticals, LLC and Daniel L. Flynn (Filed With SEC on February 9, 2021)
- Employment Agreement, between Deciphera Pharmaceuticals, LLC and Daniel L. Flynn (Filed With SEC on February 9, 2021)
- Amendment No. 1 to Employment Agreement, between Deciphera Pharmaceuticals, LLC and Thomas P. Kelly (Filed With SEC on February 9, 2021)
- Form of Non-Qualified Stock Option Agreement for Non-Employee Directors under 2017 Stock Option and Incentive Plan (Filed With SEC on February 9, 2021)
- Form of Restricted Stock Unit Award Agreement for Non-U.S. Grantees under 2017 Stock Option and Incentive Plan (Filed With SEC on February 9, 2021)
- Form of Non-Qualified Stock Option Agreement for Non-U.S. Optionees under 2017 Stock Option and Incentive Plan (Filed With SEC on February 9, 2021)
- Form of Restricted Stock Unit Award Agreement for Company Employees under 2017 Stock Option and Incentive Plan (Filed With SEC on February 9, 2021)
- Form of Non-Qualified Stock Option Agreement for Company Employees under 2017 Stock Option and Incentive Plan (Filed With SEC on February 9, 2021)
- Form of Incentive Stock Option Agreement under 2017 Stock Option and Incentive Plan (Filed With SEC on February 9, 2021)
- Amendment No. 1 to Employment Agreement, between Deciphera Pharmaceuticals, LLC and Thomas P. Kelly (Filed With SEC on August 4, 2020)
- Employment Agreement, between Deciphera Pharmaceuticals, LLC and Matthew L. Sherman (Filed With SEC on March 9, 2020)
- Deciphera Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (Filed With SEC on November 4, 2019)
- Employment Agreement, between Deciphera Pharmaceuticals, LLC and Daniel C. Martin (Filed With SEC on March 14, 2019)
- Employment Agreement, between Deciphera Pharmaceuticals, LLC and Thomas P. Kelly (Filed With SEC on March 14, 2019)
- Employee Confidentiality, Assignment and Noncompetition Agreement, dated as of March 4, 2019, by and between Deciphera Pharmaceuticals, LLC and Steven Hoerter (Filed With SEC on March 4, 2019)
- Employment Agreement, dated as of March 4, 2019, by and between Deciphera Pharmaceuticals, LLC and Steven Hoerter (Filed With SEC on March 4, 2019)
- Transition Agreement, dated as of March 4, 2019, by and between Deciphera Pharmaceuticals, Inc., Deciphera Pharmaceuticals, LLC and Michael D. Taylor (Filed With SEC on March 4, 2019)
- Employment Agreement, between Deciphera Pharmaceuticals, LLC and Oliver Rosen, M.D. to be in effect upon completion of this offering (Filed With SEC on September 25, 2017)
- Employment Agreement, between Deciphera Pharmaceuticals, LLC and Christopher J. Morl to be in effect upon completion of this offering (Filed With SEC on September 25, 2017)
- Employment Agreement, between Deciphera Pharmaceuticals, LLC and Michael D. Taylor, Ph.D. to be in effect upon completion of this offering (Filed With SEC on September 25, 2017)
- Deciphera Pharmaceuticals, Inc. Senior Executive Cash Incentive Bonus Plan (Filed With SEC on September 22, 2017)
- Deciphera Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (Filed With SEC on September 22, 2017)
- 2017 Stock Option and Incentive Plan and form of award agreements thereunder (Filed With SEC on September 22, 2017)
- 2015 Equity Incentive Plan, as amended, and form of award agreements thereunder (Filed With SEC on September 18, 2017)
